ClearBridge Investments, an investment management company, recently released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. The letter highlighted the growth experienced by midcaps in the third quarter, attributing it to shifting monetary policy, stabilizing earnings, and improved sentiment. The Federal Reserve’s decision to cut rates also contributed to the positive performance of small and mid-cap stocks during the quarter.
In the third quarter, value stocks outperformed their growth counterparts, with the Russell Midcap Value Index returning 6.2% compared to the Russell Midcap Growth’s 2.8% return. ClearBridge Mid Cap Strategy outperformed its benchmark, the Russell Midcap Index, during this period. The strategy’s stock selection in the consumer staples and healthcare sectors drove its outperformance.
One of the stocks highlighted in the investor letter was ICON Public Limited Company (NASDAQ: ICLR), a clinical research organization based in Dublin, Ireland. Despite a one-month return of -13.01% and a 19.85% decline in share value over the last 52 weeks, ICON Public Limited Company (NASDAQ: ICLR) closed at $163.42 per share on November 12, 2025, with a market capitalization of $12.479 billion.
ClearBridge Mid Cap Strategy praised ICON Public Limited Company (NASDAQ: ICLR) in its investor letter, mentioning the company’s strong performance and solid gross business wins that expanded its backlog. The organization’s success was seen as a positive sign in a challenging environment for clinical research services.
While ICON Public Limited Company (NASDAQ: ICLR) is not among the 30 most popular stocks among hedge funds, 42 hedge fund portfolios held the stock at the end of the second quarter. The company reported revenue of $2.043 billion in Q3 2025, representing a slight year-on-year increase of 0.6%.
Although there is potential for investing in ICON Public Limited Company (NASDAQ: ICLR), some AI stocks are considered to offer greater upside potential with less downside risk. For investors seeking opportunities in the AI sector, there are options available that could benefit significantly from current economic trends. To explore an undervalued AI stock that stands to gain from tariffs and the onshoring trend, a free report on the best short-term AI stock is recommended.
Overall, ClearBridge Mid Cap Strategy’s third-quarter investor letter showcased the firm’s successful stock selection in sectors like healthcare and consumer staples, with ICON Public Limited Company (NASDAQ: ICLR) being highlighted for its strong performance in a challenging industry landscape.
